INTERNAL USE COMPOSITION
To provide an internal use composition which includes hesperidin and a derivative thereof and whose preparation is inhibited from discoloring.SOLUTION: An internal use composition is prepared which includes: (A) hesperidin and/or a derivative thereof; and (B) at least one selected from the group consisting of lutein, astaxanthin, anthocyanin, α-lipoic acid, and a derivative thereof.SELECTED DRAWING: None.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 01. Dez. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
NAKAZAWA YOSUKE [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-12-01, Last update posted on www.tib.eu: 2024-04-16, Last updated: 2024-04-19 |
|---|
| Patentnummer: |
JP2023170283 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003418286 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003418286 | ||
| 003 | DE-627 | ||
| 005 | 20240419122918.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240415s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA003418286 | ||
| 035 | |a (EPA)JP2023170283 | ||
| 035 | |a (EPA)88928136 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a NAKAZAWA YOSUKE |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a INTERNAL USE COMPOSITION |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-12-01, Last update posted on www.tib.eu: 2024-04-16, Last updated: 2024-04-19 | ||
| 520 | |a To provide an internal use composition which includes hesperidin and a derivative thereof and whose preparation is inhibited from discoloring.SOLUTION: An internal use composition is prepared which includes: (A) hesperidin and/or a derivative thereof; and (B) at least one selected from the group consisting of lutein, astaxanthin, anthocyanin, α-lipoic acid, and a derivative thereof.SELECTED DRAWING: None | ||
| 650 | 4 | |a tec | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a A23L: Foods, foodstuffs, or non-alcoholic beverages, not covered by subclasses a21d or a23b-a23j; their preparation or treatment, e.g. cooking, modification of nutritive qualities, physical treatment (shaping or working, not fully covered by this subclass, a23p); preservation of foods or foodstuffs, in general | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a MORISHITA HISANORI |e verfasserin |4 aut | |
| 700 | 0 | |a ENDO SHIN |e verfasserin |4 aut | |
| 700 | 0 | |a MIYAKE MASAKI |e verfasserin |4 aut | |
| 700 | 0 | |a MIKO HITOSHI |e verfasserin |4 aut | |
| 700 | 0 | |a HAYANO MOTOSHI |e verfasserin |4 aut | |
| 700 | 0 | |a TSUBOTA KAZUO |e verfasserin |4 aut | |
| 700 | 0 | |a IIZAKA RYOTA |e verfasserin |4 aut | |
| 700 | 0 | |a OGURA CHIAKI |e verfasserin |4 aut | |
| 700 | 0 | |a MATSUMOTO NATSUKO |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 01. Dez. |
| 773 | 1 | 8 | |g year:2023 |g day:01 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88928136/publication/JP2023170283A1?q=JP2023170283 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 01 |c 12 | ||